Alternative splicing is a common mechanism for regulating gene expression and generating proteomic diversity 1,2 . Whether an alternative exon is included or excluded during splicing is often determined by cis-regulatory elements that are recognized by trans-acting regulatory proteins 3 . Two groups of classical alternative splicing regulators are the serine-arginine-rich (SR) proteins, which usually function as splicing activators, and hnRNP proteins, which often act as splicing repressors. SR proteins frequently function by recognizing exonic splicing enhancers (ESEs), whereas hnRNP proteins bind to exonic splicing silencers (ESSs) or intronic splicing silencers (ISSs) to inhibit splicing.
a r t i c l e s
Alternative splicing is a common mechanism for regulating gene expression and generating proteomic diversity 1, 2 . Whether an alternative exon is included or excluded during splicing is often determined by cis-regulatory elements that are recognized by trans-acting regulatory proteins 3 . Two groups of classical alternative splicing regulators are the serine-arginine-rich (SR) proteins, which usually function as splicing activators, and hnRNP proteins, which often act as splicing repressors. SR proteins frequently function by recognizing exonic splicing enhancers (ESEs), whereas hnRNP proteins bind to exonic splicing silencers (ESSs) or intronic splicing silencers (ISSs) to inhibit splicing.
Disruption of alternative splicing is a frequent cause of disease [4] [5] [6] [7] [8] . This can occur in several ways, including mutation of RNA sequence elements or deregulation of RNA-binding proteins 4, 5 . Mutations can destroy or weaken essential splicing signals or regulatory elements, whereas changes in expression of hnRNP, or other splicing factors, can have strong effects on alternative splicing patterns. Indeed, various diseases have been shown to involve changes in the expression levels of splicing factors 4, 5, 9 .
Regulation of PKM mRNA splicing provides an important example of an alternative splicing event that is crucial for disease and that reflects changes in the levels of hnRNP splicing regulators [10] [11] [12] . The PKM gene encodes a primary transcript that contains two mutually exclusive exons (MEEs), exon 9 and exon 10, and inclusion of one or the other leads to two different isoforms-PKM1 and PKM2, respectively 13 . PKM2 is expressed in embryonic cells whereas PKM1 is expressed in most adult tissues 14, 15 . Reversion from PKM1 to PKM2 is observed in most cancers, partially explaining the Warburg effect seen in tumor cells 16 and ensuring maximal turmorigenicity 15, 17 . We recently described a pathway that regulates PKM splicing 10 . Expression of three hnRNP proteins, hnRNPA1, hnRNPA2 and PTB, is upregulated in cancer cells by the oncogene MYC, which promotes formation of PKM2. These three hnRNP proteins, which all function as splicing repressors and are overexpressed in various cancers 5, 10, [18] [19] [20] , exclude exon 9 by binding to exon 9-flanking sequences. A subsequent study also suggested that A1, A2 and PTB are important for the PKM splicing switch 12 . But a full understanding of the molecular mechanism underlying PKM mutually exclusive alternative splicing (MEAS) has been lacking.
In this study, we provide additional insights into how PKM alternative splicing is regulated. First, using a minigene construct that accurately recapitulates PKM splicing in HeLa cells, we have identified additional PTB and hnRNPs A1 and A2 (which are highly similar and thus referred to as hnRNPA1/A2) ISSs in intron 9 that are necessary for full exclusion of exon 9. Furthermore, we have found two A1-binding sites in exon 9 that function cooperatively to facilitate A1 binding to a previously described ISS in intron 9 (ref. 10) . These A1 binding sites have a crucial role in exon 9 exclusion when hnRNPA1/A2 and PTB (the three proteins are frequently co-regulated) levels are high. When concentrations of these proteins were reduced by RNAi, exon 9 was included, as expected, but exon 10 was excluded in a manner dependent on additional hnRNPA1/A2-and PTB-binding sites in introns 9 and 10 that were effectively occupied despite the decreased concentration of these proteins. This concentration-dependent mechanism, coupled with nonsense-mediated decay (NMD), functions to prevent the appearance of PKM mRNA containing both exon 9 and exon 10. a r t i c l e s PTB recognizes two UCUU elements upstream of the 3′ splice site of exon 9, and hnRNPA1/A2 bind to UAGGGC (ISS1), which is immediately downstream of the 5′ splice site of exon 9 (ref. 10) (Fig. 1a) . To investigate whether additional intronic sequences are involved in regulating PKM splicing, we constructed a minigene splicing construct containing PKM sequences from exon 8 to exon 11, with 200-to 400-nt intronic sequences flanking each exon and with an intact 401-nt intron 9 (Fig. 1a) . This construct accurately recapitulates PKM alternative splicing in HeLa cells (see below).
Apart from the elements identified previously 10 , sequence examination (Fig. 1b) and UV cross-linking assays (Supplementary Fig. 1 ) revealed several additional hnRNPA1/A2-and PTB-binding sites in intron 9. To examine whether these sites are important for PKM splicing, we mutagenized several of them and examined the effect on PKM splicing by transfecting wild-type and mutated splicing constructs into HeLa cells and carrying out RT-PCR analysis on total cellular RNA extracts. We detected two major bands (Fig. 1c, right) . One, which we dubbed single-inclusion product (SIP), contained either exon 9 or 10 (see below), whereas the other, double-inclusion product (DIP), contained both of the MEEs.
We determined the efficiency of exon inclusion with wild-type and mutant constructs by dividing the amount of each product by the sum of both products (Fig. 1d) . With the wild-type construct, most (~97%) of the pre-mRNA produced was spliced into an SIP, and only 3.0% was DIP (Fig. 1c,d , lane 1). Additionally, similar to endogenous PKM splicing in HeLa cells, all SIP contained exon 10 (Fig. 1e, below) . Notably, TAG to TAC mutations in putative hnRNPA1/A2-binding sites 8, 10, 21, 22 markedly increased DIP, from 3.0% with the wild-type construct to 66% with the mutant (Fig. 1c,d, lanes 2 and 5) , and C to G mutations in putative PTB-binding sites increased the amount of DIP from 3.0% to 12%, indicating that these sequences contribute to exon 9 exclusion (Fig. 1c,d, lanes 1 and 3) . Last, mutations including both hnRNPA1/A2-and PTB-binding sites had the greatest effect, increasing DIP from 3.0% in the wild-type construct to 75% with the mutant (Fig. 1c,d, lane 4) . These findings suggest that efficient exon 9 exclusion involves multiple hnRNPA1/A2-and PTB-binding sites in intron 9.
To determine the amounts of exon 9 inclusion (PKM1) in the SIP, we designed exon 9-specific and exon 10-specific primers to amplify exon 9-specific or exon 10-specific SIP and DIP, respectively (Fig. 1e,  left) . Notably, in all cases all the exon 9-included product was DIP (Fig. 1e, middle) , suggesting that the release of repression of exon 9 inclusion by mutation of intron 9 ISSs led to increased DIP but not exon 9-containing SIP.
Exonic sequences are involved in PKM splicing regulation
We next set out to investigate whether cis-elements in exons function in PKM splicing regulation. First, we precisely swapped exons 9 and 10 in the wild-type splicing construct to determine whether changing the intronic sequences flanking the exons would affect splicing (Eswap; (e) Above, scheme indicates positions of exon 9-specific and exon 10-specific primers. E9F, which anneals to exon 9, and vector-specific primer BGHR were used to amplify exon 9-containing products. Vector-specific primer T7F and E10R were used to amplify exon 10-containing products. Below, RT-PCR assays with primers that amplify only exon 9-containing products to analyze splicing products from intron 9-mutated splicing constructs. Splicing constructs are indicated above, and splicing products are indicated on the left. Lane numbers correspond to those in c, and the same lane numbers represent the same constructs. npg a r t i c l e s of PKM splicing (Fig. 2a, lanes 2 and 4) . We conclude that, despite the importance of intronic sequences in intron 9 (and 8), these ISSs are not sufficient to exclude any adjacent exon. Next, we examined exon 9 and exon 10 splicing independent of each other. We precisely deleted exon 9 or 10 from the wild-type and Eswap constructs (Fig. 2b,c , above) and found that exon 10 was included efficiently in both positions (Fig. 2b) , whereas exon 9 was mainly excluded in both cases (Fig. 2c) . Thus, inclusion or exclusion of either exon was independent of its position but instead dependent on exonic sequences. We next set out to examine the possible role of exonic sequences in protein binding to PKM RNA regulatory sequences, such as ISS1. Our previous studies showed that an RNA consisting of the 3′ part of exon 9 and the 5′ part of intron 9, called EI9, was bound by hnRNPA1/A2, whereas the corresponding EI10 RNA was not 10 . However, the apparent hnRNPA1/A2-binding site, ISS1, is similar to the corresponding sequence in intron 10, ISS1-10 ( Fig. 3a, above) . We hypothesized that exonic sequences contribute to the binding profiles of EI9 and EI10. To test this idea, we carried out UV cross-linking assays with HeLa nuclear extract 22 , initially using uniformly labeled exon 9-or exon 10-containing RNAs. We prepared two RNAs for cross-linking, EI9s and EI10s, which contain the exonic region of EI9 or EI10, respectively, and a short intronic extension that contains only ISS1, ISS1-10 or mutated derivatives (Fig. 3a, above) . Similar to EI9s, both EI9sM1 and EI9sM2 mutants were bound strongly by hnRNPA1/A2 (Fig. 3a, lanes 1-3) . Moreover, mutations 'improving' ISS1-10 did not promote binding of hnRNPA1/A2 to the EI10s substrates (lanes 4-6). Our results suggest that sequences in exon 9 cooperate with ISS1 to enable hnRNPA1/A2 binding to EI9s but not EI10s.
We next examined exonic sequences and found two evolutionarily conserved TAG motifs (which we refer to as ESS1 and ESS2) in exon 9 that are absent in the homologous exon 10 (66% sequence identity). hnRNPA1 has been suggested to bind cooperatively to RNAs with multiple binding sites [23] [24] [25] [26] , so we propose that the binding of hnRNPA1/A2 to EI9s requires all three elements, ESS1, ESS2 and ISS1. To investigate this idea, we mutated the TAG to TAC or TAA in ESS1 or in both ESSs (Fig. 3b , above) and analyzed uniformly labeled RNAs by UV cross-linking. Consistent with the effects of a similar mutation (G3C) in ISS1 (ref. 10) , both mutations in ESS1 decreased hnRNPA1/A2 binding to EI9s RNA by half (Fig. 3b, lanes 3 and 6) , and the double mutant reduced the amount of A1 cross-linked to ~25% (Fig. 3b , lanes 2 and 5). Thus, although both ISS1 and ISS1-10 contain putative hnRNPA1/A2-binding sites, exon 9 harbors two elements that enable hnRNPA1/A2 to interact with EI9s RNA. To extend these results, we next used site-specifically labeled EI9s and the ESS mutants, in which the G at position 3 in ISS1 was 5′ labeled with 32 P. Notably, the results (Fig. 3c) show that, whereas EI9s was bound strongly by A1, binding was reduced to ~25% when one ESS was mutated and to ~19% when both were altered. These results indicate that the two ESSs in exon 9 facilitate hnRNPA1/A2 binding to ISS1.
These results suggest that hnRNPA1/A2 bind the exon 9 region cooperatively. To investigate this further, we purified A1 and several truncations from Escherichia coli (Fig. 3d) and carried out UV cross-linking assays with site-specifically labeled wild-type and mutant EI9s RNAs (Fig. 3e) . These results indicate (i) that hnRNPA1 alone is sufficient for binding to ISS1 and (ii) that the C-terminal domain is not essential for cooperative binding; RNA recognition motif 1 (RRM1) can be sufficient. Although the C-terminal domain has been shown to be involved in protein-protein interactions 23, 27 and it contributes to optimal binding to EI9s, our results indicate that cooperativity can be achieved in its absence.
The exon 9 hnRNPA1/A2 sites are crucial for exon exclusion To test whether the two exon 9 A1-binding sites defined above are important in regulating PKM splicing, we mutated both TAG sequences to TAC in the wild-type construct and the mutant construct A1Mu1-4 ( Fig. 4a) . Notably, the ESS mutations in the wild-type construct sharply increased DIP, from 6.1% to 90% (Fig. 4a,b a r t i c l e s whereas the same mutations in A1Mu1-4 also increased DIP, from 69% in A1Mu1-4 to 100% (Fig. 4a,b, lanes 3 and 4) . In addition, we found that, for the ESS mutant, 8.3% of the exon 9-containing products were in the form of PKM1, compared to 0% in wild type (Fig. 4c,  lanes 1 and 2) . Together, these results indicate that the ESSs in exon 9 have an important role in exon 9 exclusion. We next investigated whether other exonic sequences besides the ESSs in exon 9 are important for PKM splicing regulation. One way to address this is to create TAG elements in exon 10 while simultaneously mutating the TAGs in exon 9 into the corresponding sequences in exon 10, and determining whether these mutations are sufficient to switch PKM splicing from PKM2 to PKM1 (ESSMu; Fig. 4d , left, sequences indicated above). Mutations in ESSMu completely switched splicing from PKM2 (exon 10 inclusion) to PKM1 (exon 9 inclusion) (Fig. 4d, lanes 3 and 6) . These results indicate that the two TAG elements are the only exonic sequences that are crucial for determining whether exon 9 or exon 10 is included in proliferating cells.
Intron 9 and 10 sequences prevent double inclusion
The experiments described above have provided a detailed picture of how exon 9 is excluded from PKM mRNA to generate PKM2 mRNA.
However, when we increased exon 9 inclusion by mutating ISSs or ESSs, most of the product we detected was in the form of DIP, rather than SIP (PKM1) RNA. One explanation for this is that sequences in intron 8 and/or exon 10 that are missing in the minigene construct contribute to exon 10 exclusion. To investigate this, we first made a construct containing full-length intron 8 (WT-In8) and several derivatives containing mutations that increase exon 9 inclusion. However, none of these caused an increase in the amount of PKM1 mRNA, although the amount of DIP was less (Fig. 5a , lanes 3 and 4, and Supplementary Fig. 2) , perhaps owing to the presence of additional repressive PTB sites in the added sequences 28 . We next inserted additional intron 10 sequences (In10) into two intron 8-containing constructs, to create WT-In8-In10 and E9G3C-In8-In10. Although addition of In10 did not by itself markedly change PKM splicing relative to that obtained with WT-In8 (Fig. 5a, lanes 5 and 6) , we observed an increase in PKM1 levels (that is, M1(%)), from 2.4% to 13%, with E9G3C-In8-In10 compared with E9G3C-In8 (Fig. 5b,  lanes 2 and 3) .
We investigated whether intronic sequences contribute to exon 10 exclusion when hnRNPA1/A2 and PTB levels are reduced. To this end, we transfected WT-In8-In10 and wild-type constructs into HeLa cells a   EI9s   ESS1  123  TAG TAG   TAC TAG   TAC   TAA TAG   TAA TAA  TAC npg a r t i c l e s treated with hnRNPA1/A2 and PTB siRNA or control siRNA (knockdown efficiency was estimated by western blotting; Supplementary  Fig. 3 ). hnRNPA1/A2 and PTB knockdown greatly increased the amount of DIP in wild-type cells, from 9% in untreated cells to 90% (Fig. 5c, lanes 1 and 2) , with the derepressed exon 9 found mainly in DIP (96%) rather than PKM1 (4.1%) (Fig. 5c, lane 6) . WT-In8-In10 showed less DIP in both control and knockdown experiments than did the wild-type construct, owing to the repressive function of fulllength intron 8 (Fig. 5c , compare DIP in lanes 3 and 4 to that in lanes 1 and 2). Notably, however, following hnRNPA1/A2 and PTB depletion, the amount of PKM1 produced from WT-In8-In10 increased substantially, from 4.1% to 40% (lanes 6 and 8). The enhanced PKM1 splicing seemed to be due solely to the expanded exon 10 sequences, as splicing of WT-In8 in hnRNPA1/A2-and PTB-depleted cells did not result in increased PKM1 production (Supplementary Fig. 2) .
To confirm this, we constructed and analyzed WT-In10 and E9G3C-In10, which contain intact intron 10 but not intron 8. WT-In10 showed a similar effect in reducing DIP and increasing SIP (38% PKM1) when hnRNPA1/A2 and PTB were depleted (Fig. 5d, lanes 6-8) as did WT-In8-In10 (lane 7) (35% of PKM1). Similarly, E9G3C-In10 showed increased PKM1 compared to E9G3C, from 8.4% to 23% (Fig. 5b, lanes 1 and 4) . Together, these results indicate that fulllength intron 10 enhances PKM1 production by reducing exon 10 inclusion when hnRNPA1/A2 and PTB levels are reduced. We were unable to identify a specific region of intron 10, as constructs containing various intron 10 truncations failed to produce PKM1 (Supplementary Fig. 4) .
We next asked whether intron 9 sequences have a similar role in preventing double inclusion. First, several internal deletions of intron 9 in WT-In10 resulted in large reductions in PKM1 RNA levels, with a concomitant increase in DIP when hnRNPA1/A2 and PTB levels were reduced (Fig. 6a) , indicating that PKM1 production enhanced by full-length intron 10 also depends on full-length intron 9. We next cloned full-length intron 10 into the various intron 9 mutants analyzed in Figure 1 and examined whether the hnRNPA1/A2-and PTB-binding sites in intron 9 have a role in exon 10 exclusion when hnRNPA1/A2 and PTB levels are reduced. Consistent with the intron deletion results, these mutations greatly reduced PKM1 levels and increased DIP when hnRNPA1/A2 and PTB levels were reduced (Fig. 6b, compare lanes 8, 10 and 12, and Supplementary Fig. 5 
a r t i c l e s
Notably, we found that mutation of the two most distal hnRNPA1/A2-binding sites in intron 9 did not affect exon 9 exclusion when hnRNPA1/A2 and PTB levels were high (Fig. 6c, lane 3 ; see also Fig. 1e ) but was sufficient to reduce exon 10 exclusion when hnRNPA1/A2 and PTB levels were low (Fig. 6c, lanes 10-12) .
Reduced levels of hnRNPA1 and PTB exclude exon 10
The results reported here suggest that hnRNPA1/A2 and PTB have dual roles in PKM splicing regulation. When hnRNPA1/A2 and PTB levels are high, the proteins bind strongly to sites in and around exon 9 to repress its inclusion, but when hnRNPA1/A2 and PTB levels are reduced, hnRNPA1/A2 and PTB binding to the exon 9-proximal sites is more markedly reduced than is binding to the intronic sites flanking exon 10, and this functions to prevent exon 10 inclusion. To test this hypothesis, we carried out cross-linking immunoprecipitation (CLIP) 29 using a hnRNPA1 antibody to detect A1 binding in cells at different positions on the PKM pre-mRNA (Fig. 6d) in both control siRNA-treated and hnRNPA1/A2 and PTB siRNA-treated HeLa cells. We quantified A1 binding by dividing RT-PCR values from immunoprecipitation signals by those from input RNA signals; binding at the 5′ splice site of exon 9 in control siRNA-treated cells was set to 1.0. As expected, A1 binding to the 5′ splice site of exon 9 was higher than to the 5′ splice site of exon 10, consistent with its role in repressing exon 9 inclusion. Binding of A1 to the 5′ splice site of exon 9 was reduced by about 50% after hnRNPA1/A2 levels were reduced (Supplementary Fig. 6 ). Notably, however, A1 binding to a region that included A1-binding sites 5 and 6 (amplified by In9f3r3) did not decrease after hnRNPA1/A2 depletion, whereas A1 binding to three regions in intron 10 containing consensus A1-binding sites actually increased (Fig. 6e and Supplementary Fig. 6 ). In vitro UV cross-linking experiments with purified A1 showed that the differences in A1 cross-linking in vivo were not due to intrinsic differences in affinity (Supplementary Fig. 7) . We also examined binding of PTB to introns 8 and 9. As expected, binding of PTB to the site immediately upstream of exon 9 (In8f1r1) was reduced after hnRNPA1/A2 and PTB knockdown. However, binding to sites in intron 9 (In9PTBf1r1 and In9PTBf2r2) was not reduced (Fig. 6f and Supplementary Fig. 8 ). These results suggest that, as with hnRNPA1/A2, exon 9-proximal PTB binding was more sensitive to a reduction in PTB levels than was PTB binding deep within introns. The fact that the hnRNP proteins remained bound to the intron 9 and intron 10 sites after their partial depletion, along with the functional importance of the corresponding PTB and hnRNPA1/A2 consensus sites in preventing double inclusion, point to a role for these proteins when present at reduced levels in prevention of DIP by inhibiting exon 10 inclusion (see Discussion). a r t i c l e s in more detail, as well as the implications of our results with respect to alternative splicing control more generally. Although the details of the mechanism of exon 9 exclusion by cooperative binding of hnRNPA1/A2 differ from other well-studied examples, overall it is consistent with a number of previous observations and seems to hinge on the ability of hnRNPA1 to dimerize or multimerize. For example, when A1 binds to two intronic binding sites flanking HNRNPA1 exon 7b, it 'loops out' the intervening RNA to repress exon inclusion 35, 36 . However, PKM exon 9 exclusion is unlikely to involve an RNA loop, as the crucial A1-binding sites, the two ESSs and the site overlapping the 5′ splice site, are in close juxtaposition. It is likely that hnRNPA1, through cooperative interactions, forms a multimer that spans the 5′ splice site and sterically blocks U1 small nuclear ribonucleic protein (snRNP) binding. Although it has been shown that ISSs situated near a 5′ splice site can interfere with U1 snRNP function but not binding 37 , in our case the overlapping nature of the sites strongly suggests that binding is inhibited.
Another repression model, known as the propagation model, is also based on A1 cooperative binding and suggests that A1 molecules spread along RNAs following binding to a high-affinity site 26, 27 . Although this is unlikely to apply to PKM splicing, as the principal mechanism of exon 9 exclusion involves cooperative binding to closely spaced sites, our finding that additional A1 sites situated downstream in intron 9 are important for full repression suggests that a more extensive array of bound A1 molecules contributes to exclusion. Although the cooperative binding of A1 just described has a crucial role, cross-talk between hnRNPA1/A2 and PTB proteins also contributes. For example, our data, reported here and previously 10 , indicate that interactions involving several PTB sites in intron 8 contribute to repression by interfering with U2AF binding to the 3′ splice site of exon 9 (ref. 10) . Taken together, our findings indicate that the repressive context formed by the network of hnRNP-binding sites is more extensive than we previously envisioned. Our data also show that the precise location of the exon within the inhibitory network is secondary to the presence or absence of ESS sequences within the exon, indicating a high degree of flexibility in the evolution of splicing regulation. Figure 7 A model for PKM mutually exclusive splicing. (a) PKM2 mRNA production. In the presence of elevated levels of hnRNPA1/A2 and PTB, as in proliferating or cancer cells, hnRNPA1/ A2 bind to two ESS elements in exon 9 and ISS1 in intron 9 through cooperative binding (onedirectional arrow), excluding exon 9 (wild type). PTB and additional hnRNPA1/A2 molecules bind to both intron 8 (PTB only) and intron 9. This further inhibits exon 9 inclusion, through formation of an inhibitory network of hnRNPs through protein-protein interactions (two-directional arrow). (b) PKM1 mRNA production. When hnRNPA1/ A2 and PTB are expressed at low levels, as in differentiated cells, binding in and around exon 9 is unable to compete with the splicing machinery, exon definition occurs and exon 9 is included. However binding to sites in the distal part of intron 9 and in intron 10 persists or is even increased at these low levels of hnRNPA1/A2 and PTB, and interactions between these molecules now excludes exon 10, probably through RNA looping. Unlike with exon 9 in the presence of high hnRNP levels, exon 10 exclusion is not complete. Therefore, double-inclusion mRNA containing both exon 9 and exon 10 is produced but is degraded by NMD.
NMD eliminates PKM double-inclusion mRNA
Although these data show that sequences in the introns flanking exon 10 function to reduce double inclusion, nonetheless, we still detected a substantial amount of DIP mRNA. By contrast, double included product was never detected from the endogenous. Exons 9 and10 are both 167 nt in size, so a double-inclusion mRNA results in a frameshift and generation of a premature stop codon. This suggests that PKM DIP would be subject to NMD, a process that influences alternative splicing outcomes [30] [31] [32] [33] . To test this hypothesis, we treated HeLa cells with cycloheximide, a translation inhibitor that blocks NMD, when hnRNPA1/A2 and PTB were depleted using siRNAs, and we measured PKM mRNA by RT-PCR (Fig. 6g) . A PKM DIP indeed appeared in the presence but not the absence of cycloheximide (lanes 3 and 4). We did not detect double-inclusion mRNA when cells were treated with cycloheximide but not siRNAs (lane 2). We confirmed this result by depleting Upf1, a factor required for NMD 34 , together with PTB and hnRNPA1/A2 depletion (data not shown). We conclude that NMD helps to prevent accumulation of DI PKM transcript in cells in which exon 9 exclusion is derepressed.
DISCUSSION
In this study, we have provided a detailed analysis of the mechanism involved in regulation of an important MEAS event, the switch that determines whether PKM1 or PKM2 mRNA is made. Our data suggest that this mechanism is on the one hand simple, requiring only the activity of several well-characterized RNA-binding splicing repressors, but on the other hand complex, involving multiple cis-elements in and around the two alternative exons that respond differently to varying levels of these proteins. Our experiments indicate that the splicing repressors hnRNPA1/A2 and PTB are sufficient to control exon 9 exclusion and exon 10 inclusion in proliferating cells. Notably, we show that hnRNPA1/A2 and PTB have a second role in PKM splicing. When their levels are reduced, they are displaced from binding sites flanking exon 9 but remain bound to intronic regions flanking exon 10, where they act to prevent exon 10 inclusion. Exon 10 exclusion, however, is not complete, and NMD functions to remove DIP (Fig. 7) . Below we discuss these mechanisms npg a r t i c l e s Another important aspect of our work is our demonstration that hnRNPA1/A2 and PTB have dual roles in PKM splicing, depending on their expression levels. How might the switch from repression of one exon to another occur? We suggest the following model (Fig. 7) . When hnRNPA1/A2 levels are high, the proteins bind to multiple sites in intron 9 and intron 10 and also bind strongly to exon 9 and the 5′ splice site of exon 9, resulting in exon 9 exclusion. However, at lower levels, they are less able to compete with the splicing machinery for binding to the 5′ splice site of exon 9, exon definition occurs and the hnRNP proteins are displaced. By contrast, hnRNPA1/A2 bound to sites deep in intron 9 are not subject to competition with the splicing machinery, and occupancy is therefore not decreased, even when hnRNPA1/A2 levels are sharply reduced. PTB behaves in a similar manner: exon 9-proximal binding is more sensitive to low PTB levels, whereas intronic binding is maintained.
Notably, A1 binding to intron 10 sites is actually increased when hnRNPA1/A2 levels are reduced. Given the high degree of cooperativity in A1 RNA binding, shown here and elsewhere, we hypothesize that this increased binding results from cooperative interactions with A1 molecules bound to intron 9. When hnRNPA1/A2 levels are high, hnRNPA1/A2 molecules bound in and around exon 9 interact with hnRNPA1/A2 bound to intron 9, contributing to exon 9 exclusion and precluding their interaction with molecules bound to the intron 10 sites. This may also be favored simply by the fact that the upstream sites are transcribed first and are therefore available for binding before the downstream sites. After displacement of hnRNPA1/A2 from the 5′ splice site of exon 9, intron 9-bound hnRNPA1/A2 molecules interact with and promote hnRNPA1/A2 binding to the intron 10 sites, explaining the increased binding of hnRNPA1/A2 to intron 10 observed at lower hnRNPA1/A2 and PTB levels. Such cross-exon interactions would probably form an RNA loop, resulting in exon 10 exclusion. An important implication of these results is the likelihood that exonic hnRNP binding is more sensitive to changes in cellular hnRNP concentration than is binding to intronic sites, owing to competition with the splicing machinery. This concept is likely to have broad implications for regulation of alternative splicing in general.
Accumulation of double-inclusion PKM mRNA is also limited by NMD 38 . Up to one-third of alternative splicing events create a premature termination codon (PTC) 38 . Our data show that there is a role for this process in PKM splicing regulation, but they raise the question of whether NMD is commonplace in MEAS regulation. To address this, we searched the MEAS events identified previously 1 and analyzed the 34 genes in which two alternatively spliced exons were annotated in the UCSC Genome browser. Among the 34 MEAS events, 25 transcripts would contain a PTC that triggers NMD when both exons are included. Of the nine transcripts that would not create a PTC, six of them contain a short intron between the two mutually exclusive exons (from 1-64 nt). Given that a minimum size of ~66 nt is required for splicing in mammalian cells 39 , this small size is by itself sufficient to prevent DIP. This analysis suggests that NMD and short intron size provide two mechanisms that are generally used to prevent double inclusion during MEAS. As we found with PKM, this implies that regulation of inclusion or exclusion of only one of the two mutually exclusive exons must be stringently regulated during MEAS.
Here we provide a detailed picture of how MEAS can be regulated. hnRNPs A1 and A2 and PTB are sufficient to regulate PKM splicing, and this occurs through a network of binding sites that respond differently to varying levels of the proteins. It will be of interest in the future to learn how widely this simple mechanism, or related ones, is used to regulate MEAS.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
